Axon Biology & The Future of Drug Discovery: A Deep Dive with Dr Federico Dajas-Bailador

News-Medical sits down with Dr. Federico Dajas-Bailador, a leading expert in axon biology and drug discovery.

HHS cracks down on hidden insurance fees – Pharmaceutical Technology

The US HHS is proposing policy changes to increase transparency surrounding insurance costs. Credit: fizkes via Shutterstock. The US Department of Health and Human Services

July 10, 2023

Baxter pulls IV products out of China to shift supply to the US

Baxter has “suspended commercial activities” of its intravenous products in China to ease supply issues in the US caused by Hurricane Helene, the company told

November 2, 2024

Charles River shipments of research monkeys to Canada spark a probe

A charter company working for Charles River Laboratories, one of the largest U.S. clinical research organizations, was recently fined by Canadian authorities for improperly shipping

October 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.